A

AstraZeneca

Global pharmaceutical company developing prescription medicines

Executive Director - Cancer Vaccine Neoantigen Engineering, Early Infectious Disease

Translational Research & Bench BiologyPosted on Nov 10
Full-timeCambridge, MA, USA$281.9k - $422.8k /yrIn-person

About the Job

Requirements

  • PhD or equivalent in bioinformatics, immunology, oncology, molecular biology, biochemistry, or a related discipline, with 10 or more years of industry experience.
  • Proven experience developing vaccines targeting different antigens across a variety of disease settings.
  • Proven experience generating multiple vaccine constructs and testing them to identify optimal vaccine-candidate designs.
  • Experience working in a cross-functional team to maximize expertise and accelerate success.
  • Experience developing and implementing novel methods to support vaccine development.
  • Experience supporting or leading interdisciplinary vaccine discovery or development programs.
  • Proven experience leading and managing junior colleagues.
  • Proven experience developing and controlling budgets.
  • Business analysis and consultancy skills.

Responsibilities

  • Lead molecular engineering and construction of a portfolio of cancer vaccines designed to generate broad, potent, and durable anti-tumor cellular immunity.
  • Identify, prioritize, and engineer diverse tumor antigen classes and translate them into precision multi-antigen and epitope constructs optimized for T-cell breadth, clonal expansion, functional potency, and long-term immune surveillance.
  • Build capabilities to master antigen processing, pMHC presentation, and TCR recognition, integrating genomic, transcriptomic, immunopeptidomic, structural, and TCR repertoire data to understand antigen presentation, immune visibility, and functional tumor-cell killing.
  • Establish predictive design principles for epitope selection and immunogen engineering.
  • Develop antigen-cassette architectures that induce cellular immunity, balancing immunodominance, coordinating CD8+ cytotoxicity with CD4+ T-cell help, minimizing antigen escape, and maximizing the magnitude, breadth, polyfunctionality, cytotoxicity, and persistence of vaccine-induced T-cell responses.
  • Establish an integrated antigen-engineering engine connecting computational design with experimental validation and iterative optimization.
  • Build differentiated capabilities and intellectual property in engineered immunogens, multi-antigen cassette architectures, immune-routing strategies, and sequence-design algorithms to create a scalable platform for predictive cancer-vaccine design.
  • Establish an epitope discovery, validation, and engineering pipeline.
  • Optimize epitope sequence design and create a multi-antigen architectural design tool.
  • Engineer antigen expression constructs to maximize T-cell breadth, clonal expansion, and durability.
  • Create intellectual property around epitope design and antigen-construct architecture.
  • Work with cross-disciplinary teams to guide iterative antigen design and preclinical evaluation.
  • Establish strategic relationships across the organization and functions.
  • Build a group and expertise around vaccine-candidate design, accounting for target antigens and target indications.
  • Foster relationships with senior and executive stakeholders in Research, Bioprocess Development, Clinical and Translational Medicine, and Global Project Teams to ensure cross-functional alignment.
  • Develop AI-based strategies to accelerate research innovation.
  • Collaborate on and guide evaluation of novel business-development opportunities.
  • Communicate results internally and externally, including associated risks, uncertainties, and limitations.
  • Define training standards for junior colleagues in line with best practices and principles.

About the Company

AstraZeneca

Global pharmaceutical company developing prescription medicines

AstraZeneca develops and markets prescription medicines and vaccines worldwide, with a focus on oncology, cardiovascular/metabolic, respiratory, and infectious diseases. Its products work by targeting specific biological pathways or cells, using small-molecule therapies, biologics, and vaccines to treat diseases or prevent infections. It differentiates itself through its dual heritage from Sweden and the UK, a broad pipeline, and strong R&D and collaborations that move from discovery to patient access. Its goal is to improve people’s health by discovering, developing, and delivering medicines and vaccines to patients worldwide.

Company size
10,001+
Company stage
IPO
Headquarters
Cambridge, United Kingdom
Founded
1913

Recently Posted Jobs

Explore more opportunities at AstraZeneca

See more jobs